Classical Complement Pathway Inhibitor [EPC]

321 reported adverse events

Drugs of this class: SUTIMLIMAB-JOME

These side effects are most commonly reported by patients taking drugs of the Classical Complement Pathway Inhibitor [EPC] class:

# Side effect Count
0 OFF LABEL USE 39
1 HAEMOGLOBIN DECREASED 23
2 ARTHRALGIA 20
3 FATIGUE 18
4 DEATH 16
5 HAEMOLYSIS 16
6 CONDITION AGGRAVATED 15
7 DRUG INEFFECTIVE 13
8 HEADACHE 13
9 COVID-19 12
See all common reactions for Classical Complement Pathway Inhibitor [EPC]

Drugs of the Classical Complement Pathway Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 B-CELL MALIGNANCY 1 0.5000
1 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 4 0.0110
2 COLD TYPE HAEMOLYTIC ANAEMIA 2 0.0085
3 HEPATITIS VIRAL 4 0.0050
4 AUTOANTIBODY POSITIVE 1 0.0036
5 INFECTION REACTIVATION 4 0.0035
6 BLOOD IMMUNOGLOBULIN M INCREASED 2 0.0033
7 SICKLE CELL ANAEMIA 2 0.0031
8 HAPTOGLOBIN DECREASED 2 0.0025
9 HAEMOLYSIS 16 0.0021
See all enriched reactions for Classical Complement Pathway Inhibitor [EPC]